Titel

Merkliste
1 Ergebnisse

Table_1_Protocol for a randomized, placebo-controlled, doub..:

Andreas W. Wolff ; Helen Bidner ; Yvonne Remane...
https://figshare.com/articles/dataset/Table_1_Protocol_for_a_randomized_placebo-controlled_double-blind_phase_IIa_study_of_the_safety_tolerability_and_symptomatic_efficacy_of_the_ROCK-inhibitor_Fasudil_in_patients_with_Parkinson_s_disease_ROCK-PD_PDF/25216637. , 2024

Link: https://doi.org/10.3389/fnagi.2024.1308577.s001

RT Journal
T1 <Title>Table_1_Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson's disease (ROCK-PD).PDF</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonianinsp:oai:figshare.com:article_25216637&Exemplar=1&LAN=DE
				
A1 Andreas W. Wolff
A1 Helen Bidner
A1 Yvonne Remane
A1 Janine Zimmer
A1 Dag Aarsland
A1 Olivier Rascol
A1 Richard K. Wyse
A1 Alexander Hapfelmeier
A1 Paul Lingor
YR 2024
K1 Neuroscience
K1 Pathology
K1 Health Care
K1 Psychiatry (incl. Psychotherapy)
K1 Clinical Sciences not elsewhere classified
K1 Central Nervous System
K1 Aged Care Nursing
K1 Aged Health Care
K1 Protein Trafficking
K1 Parkinson's disease
K1 clinical trial
K1 safety
K1 tolerability
K1 symptomatic efficacy
K1 disease modification
K1 Fasudil
K1 ROCK inhibition
JF https://figshare.com/articles/dataset/Table_1_Protocol_for_a_randomized_placebo-controlled_double-blind_phase_IIa_study_of_the_safety_tolerability_and_symptomatic_efficacy_of_the_ROCK-inhibitor_Fasudil_in_patients_with_Parkinson_s_disease_ROCK-PD_PDF/25216637
LK http://dx.doi.org/https://doi.org/10.3389/fnagi.2024.1308577.s001
DO https://doi.org/10.3389/fnagi.2024.1308577.s001
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)